Siemens Healthineers to Rebrand In Vitro Diagnostics Business as Olyrian Diagnostics
Tarrytown, New York, USA, Nov. 05, 2026 (GLOBE NEWSWIRE) -- The company is preparing its Diagnostics business to become a standalone organization The name, Olyrian Diagnostics, will be rolled out in stages Olyrian will advance diagnostics along the care continuum, from patient draw to population health Siemens Healthineers announced today it has initiated the carve-out process for its in vitro diagnostics business, marking an important step toward establishing a standalone company that will operate under the name Olyrian Diagnostics.
Wil je dit soort signalen real-time en gefilterd op jouw eigen watchlist?
Krijg push-meldingen, dieptanalyses en data-edge inzichten, afgestemd op de assets die jij volgt.
Probeer Premium 14 dagen voor €1Eerst een gratis overzicht? Start met Vermogensbeeld
Beleggen kent risico's. Educatief, geen advies.